GR3007465T3 - - Google Patents

Info

Publication number
GR3007465T3
GR3007465T3 GR930400653T GR930400653T GR3007465T3 GR 3007465 T3 GR3007465 T3 GR 3007465T3 GR 930400653 T GR930400653 T GR 930400653T GR 930400653 T GR930400653 T GR 930400653T GR 3007465 T3 GR3007465 T3 GR 3007465T3
Authority
GR
Greece
Prior art keywords
concerned
chem
esters
compound
formula
Prior art date
Application number
GR930400653T
Other languages
Greek (el)
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3007465T3 publication Critical patent/GR3007465T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Quinoline Compounds (AREA)
GR930400653T 1988-08-25 1993-03-24 GR3007465T3 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888820174A GB8820174D0 (en) 1988-08-25 1988-08-25 Quinoline compound

Publications (1)

Publication Number Publication Date
GR3007465T3 true GR3007465T3 (enExample) 1993-07-30

Family

ID=10642685

Family Applications (1)

Application Number Title Priority Date Filing Date
GR930400653T GR3007465T3 (enExample) 1988-08-25 1993-03-24

Country Status (9)

Country Link
US (1) US5010088A (enExample)
EP (1) EP0356230B1 (enExample)
JP (1) JPH02108688A (enExample)
AT (1) ATE86990T1 (enExample)
CA (1) CA1318672C (enExample)
DE (1) DE68905406T2 (enExample)
ES (1) ES2054007T3 (enExample)
GB (1) GB8820174D0 (enExample)
GR (1) GR3007465T3 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8820174D0 (en) * 1988-08-25 1988-09-28 Wellcome Found Quinoline compound
JP2686887B2 (ja) * 1992-08-11 1997-12-08 キッセイ薬品工業株式会社 ピペリジノ−３，４−ジヒドロカルボスチリル誘導体
US6566372B1 (en) 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
EP1212322A2 (en) 1999-08-27 2002-06-12 Ligand Pharmaceuticals Incorporated 8-substituted-6-trifluoromethyl-9-pyrido[3,2-g]quinoline compounds as androgen receptor modulators
MXPA02002032A (es) 1999-08-27 2003-05-19 Ligand Pharm Inc Compuestos moduladores del receptor de androgeno y metodos.
US6593493B1 (en) 1999-09-14 2003-07-15 Ligand Pharmaceuticals, Inc. RXR modulators with improved pharmacologic profile
IL150650A0 (en) 2000-01-20 2003-02-12 Eisai Co Ltd Piperidine derivatives and pharmaceutical compositions containing the same
BRPI0413820A (pt) 2003-08-22 2006-10-24 Ligand Pharm Inc derivados de 6-cicloamino-2-quinolinona como compostos moduladores de receptor de androgênio

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60126270A (ja) * 1983-12-14 1985-07-05 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体
US4760064A (en) * 1984-12-18 1988-07-26 Otsuka Pharmaceutical Co., Ltd. Carbostyril compounds, compositions containing same and processes for preparing same
DK111387A (da) * 1986-03-05 1987-09-06 Otsuka Pharma Co Ltd Carbostyrilderivater og salte deraf, laegemiddel indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne
US4921862A (en) * 1986-05-29 1990-05-01 Syntex (U.S.A.) Inc. Carbostyril derivatives as combined thromboxane synthetase and cyclic-amp phosphodiesterase inhibitors
EP0255134B1 (en) * 1986-07-31 1993-03-03 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and salts thereof, process for preparing them, and cardiotonic composition containing same
GB8630702D0 (en) * 1986-12-23 1987-02-04 Wellcome Found Quinoline compound
JPH01145162A (ja) * 1987-12-01 1989-06-07 Matsushita Electric Ind Co Ltd 電極ヘッド
GB8820174D0 (en) * 1988-08-25 1988-09-28 Wellcome Found Quinoline compound

Also Published As

Publication number Publication date
ATE86990T1 (de) 1993-04-15
US5010088A (en) 1991-04-23
DE68905406D1 (de) 1993-04-22
GB8820174D0 (en) 1988-09-28
CA1318672C (en) 1993-06-01
DE68905406T2 (de) 1993-09-23
EP0356230A1 (en) 1990-02-28
EP0356230B1 (en) 1993-03-17
JPH02108688A (ja) 1990-04-20
ES2054007T3 (es) 1994-08-01

Similar Documents

Publication Publication Date Title
IL148516A (en) Retroviral protease inhibiting compound
AU8293387A (en) Quinoline compound
GR3017559T3 (en) Novel A-nor-steroid-3-carboxylic acid derivatives.
ZA911502B (en) A pharmaceutical solution
TW232013B (enExample)
GR3007460T3 (enExample)
GB8820174D0 (en) Quinoline compound
GR3001551T3 (en) Derivatives of benzoquinonyl-phenyl alkanoic acid amide
AU560424B2 (en) Esters of 2-bromo-4-methylimidazole-5-carboxylic acid
GR3005734T3 (enExample)
AU566243B2 (en) Optically active imidazolylpropanols
DE3587915D1 (de) Verfahren zur Herstellung von Cephalosporinen.